BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Cisplatin, rs3825942, FGF21, Coagulation, Inflammatory disorder, Pancreas)
Bookmark Forward

QuickView for CDKN2A (gene)


Body Atlas

Most Correlated Tissues

  1. Plasma cell of spleen
  2. Parotid gland
  3. Skeletal muscle psoas
  4. Microglial cell
  5. Ascending colon
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Disease due to Papilloma virus
  2. Human papilloma virus infection
  3. Skin cancer
  4. Uterine cancer
  5. Malignant tumor of muscle
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Lincomycin
  2. sodium selenate
  3. Dexfenfluramine
  4. aceclofenac
  5. Teicoplanin
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. USP27X
  2. FRY
  3. EED
  4. CDKN1B
  5. NR5A1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Loss of p19Arf promotes fibroblast survival during leucine deprivation.
  2. Autophagy regulates the localization and degradation of p16INK4a.
  3. ARF GTPases activate Salmonella effector SopF to ADP-ribosylate host V-ATPase and inhibit endomembra…
  4. P14ARF: The Absence that Makes the Difference.
  5. The reduced ARF regulatory system in Giardia intestinalis pre-dates the transition to parasitism in …
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors
  2. Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Can…
  3. Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelat…
  4. Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperativ…
  5. Pilot Study of Abemaciclib With Bevacizumab in Recurrent Glioblastoma Patients With Loss of CDKN2A/B…
Explore Clinical Trials Results
  • Copyright © 2022 Illumina Inc. All rights reserved.